secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECTIS HEALTH, INC. (GBCS)
CIK:        0000727346
Form:       8-K
Filed at:   2022-03-09T23:59:59+00:00
Accession:  0001493152-22-006350
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Selectis Health CFO Brandon Thall resigns; Controller Christine Lucus named interim CFO
--------------------------------------------------------------------------------

- Brandon Thall resigned as CFO effective March 4, 2022; immediate departure.
- Christine Lucus, former Controller, appointed interim CFO effective March 4, 2022.
- Lucus base salary $135,000/year; eligible for $15,000 bonus for timely SEC filings.
- Lucus previously Controller at Neubase Therapeutics (NASDAQ) and has 7 years experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/727346/000149315222006350/0001493152-22-006350-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/727346/000149315222006350/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-006350

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer